Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Lanza

Showing results (71-80 of 167) with videos related to

Pageof 17
Sort By:
Cytotherapy|February 9, 2011
JACIE celebrates its 10-year anniversary with the demonstration of improved clinical outcomeChristian Chabannon, Derwood Pamphilon, Christiane Vermylen, et al.
Haematologica|March 15, 2006
The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypesFrancesco Albano, Anna Mestice, Alessandra Pannunzio, et al.
American Journal of Hematology|June 15, 2017
A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approachFrancesco Lanza, Francesco Saraceni, Annalisa Pezzi, et al.
Ophthalmology|November 13, 2017
Proton Beam Therapy for Iris Melanomas in 107 PatientsJuliette Thariat, Ahmed Rahmi, Julia Salleron, et al.
Cytotherapy|January 21, 2018
Handling, processing and disposal of stem cell products in Europe: A survey by the cellular therapy and immunobiology working party of the European Society for Blood and Marrow TransplantationAndreas Holbro, Helen Baldomero, Francesco Lanza, et al.
Bone Marrow Transplantation|January 26, 2018
Secondary malignancies after high-dose chemotherapy in germ cell tumor patients: a 34-year retrospective study of the European Society for Blood and Marrow Transplantation (EBMT)Andrea Necchi, Salvatore Lo Vullo, Simona Secondino, et al.
Journal of Medical Case Reports|November 7, 2024
Management of iatrogenic atrial perforation caused by pacemaker electrodes: a case reportGraziano Fiorillo, Seyedali Ghazihosseini, Simone Agizza, et al.
Audiology & Neuro-Otology|March 4, 2015
The prevalence of peripheral and central hearing impairment and its relation to cognition in older adultsNicola Quaranta, Francesco Coppola, Mara Casulli, et al.
Cancers|September 28, 2021
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab OzogamicinMichele Gottardi, Giorgia Simonetti, Alessandra Sperotto, et al.
Blood Cancer Journal|June 30, 2026
Dynamics of IDH1/2 mutated clones in acute myeloid leukemia challenge their use as universal MRD markersGiovanni Marconi, Lorenza Bandini, Agnese Patuelli, et al.
Pageof 17

Showing results (71-80 of 167) with videos related to

Sort By:
Pageof 17
Cytotherapy|February 9, 2011
JACIE celebrates its 10-year anniversary with the demonstration of improved clinical outcomeChristian Chabannon, Derwood Pamphilon, Christiane Vermylen, et al.
Haematologica|March 15, 2006
The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypesFrancesco Albano, Anna Mestice, Alessandra Pannunzio, et al.
American Journal of Hematology|June 15, 2017
A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approachFrancesco Lanza, Francesco Saraceni, Annalisa Pezzi, et al.
Ophthalmology|November 13, 2017
Proton Beam Therapy for Iris Melanomas in 107 PatientsJuliette Thariat, Ahmed Rahmi, Julia Salleron, et al.
Cytotherapy|January 21, 2018
Handling, processing and disposal of stem cell products in Europe: A survey by the cellular therapy and immunobiology working party of the European Society for Blood and Marrow TransplantationAndreas Holbro, Helen Baldomero, Francesco Lanza, et al.
Bone Marrow Transplantation|January 26, 2018
Secondary malignancies after high-dose chemotherapy in germ cell tumor patients: a 34-year retrospective study of the European Society for Blood and Marrow Transplantation (EBMT)Andrea Necchi, Salvatore Lo Vullo, Simona Secondino, et al.
Journal of Medical Case Reports|November 7, 2024
Management of iatrogenic atrial perforation caused by pacemaker electrodes: a case reportGraziano Fiorillo, Seyedali Ghazihosseini, Simone Agizza, et al.
Audiology & Neuro-Otology|March 4, 2015
The prevalence of peripheral and central hearing impairment and its relation to cognition in older adultsNicola Quaranta, Francesco Coppola, Mara Casulli, et al.
Cancers|September 28, 2021
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab OzogamicinMichele Gottardi, Giorgia Simonetti, Alessandra Sperotto, et al.
Blood Cancer Journal|June 30, 2026
Dynamics of IDH1/2 mutated clones in acute myeloid leukemia challenge their use as universal MRD markersGiovanni Marconi, Lorenza Bandini, Agnese Patuelli, et al.
Pageof 17